Filing Details

Accession Number:
0001209191-15-075019
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-09 16:03:48
Reporting Period:
2015-10-07
Filing Date:
2015-10-09
Accepted Time:
2015-10-09 16:03:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557746 Aclaris Therapeutics Inc. ACRS Pharmaceutical Preparations (2834) 460571712
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397906 Albert Cha C/O Aclaris Therapeutics, Inc.
101 Lindenwood Drive, Suite 400
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-07 13,352 $11.00 303,206 No 4 P Indirect By funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By funds
Footnotes
  1. The reporting person is one of the managing members of Vivo Ventures VII, LLC ("VV LLC"), which is the general partner of each of Vivo Ventures Fund VII, L.P. ("VVF") and Vivo Ventures VII Affiliates Fund, L.P. ("VVAF"), the record holders of the securities, and may be deemed to share voting and dispositive power over the securities held by VVF and VVAF. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.